Cadee JA, Brouwer LA, den OW, Hennink WE, and van Luyn MJ. (2001). A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats. J Biomed Mater Res 56: 600-9. PubMed

 

De Groot CJ, van Luyn MJ, Van Dijk-Wolthuis WN, Cadee JA, Plantinga JA, den OW, and Hennink WE. (2001). In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts. Biomaterials 22: 1197-203. PubMed

 

Geertsema AA, Schutte HK, Rakhorst G, van Luyn MJ, Mahieu HF, and Verkerke GJ. (2001). A novel tracheal tissue connector for fixation of laryngeal prostheses. Biomaterials 22: 1571-8. PubMed

 

Greijer AE, Verschuuren EA, Harmsen MC, Dekkers CA, Adriaanse HM, The TH, and Middeldorp JM. (2001). Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification. J Clin Microbiol 39: 251-9. PubMed

 

Kas-Deelen AM, Bakker WW, Olinga P, Visser J, de Maar EF, van Son WJ, The TH, and Harmsen MC. (2001). Cytomegalovirus infection increases the expression and activity of ecto-ATPase (CD39) and ecto-5'nucleotidase (CD73) on endothelial cells. FEBS Lett 491: 21-5. PubMed

 

Kas-Deelen AM, de Maar EF, van der Mark TW, Harmsen MC, van Son WJ, and The H. (2001). Pulmonary diffusion abnormalities in relation to cytomegalovirus antigenemia and cytomegalic endothelial cells in blood. Transpl Int 14: 180-3. PubMed

 

Kas-Deelen AM, The TH, Blom N, van der Strate BW, de Maar EF, Smit J, van Son WJ, and Harmsen MC. (2001). Uptake of pp65 in in vitro generated pp65-positive polymorphonuclear cells mediated by phagocytosis and cell fusion? Intervirology 44: 8-13. PubMed

 

Khouw IM, van Wachem PB, Plantinga JA, de Leij LF, and van Luyn MJ. (2001). Enzyme and cytokine effects on the impaired onset of the murine foreign-body reaction to dermal sheep collagen. J Biomed Mater Res 54: 234-40. PubMed

 

McLaughlin PM, Harmsen MC, Dokter WH, Kroesen BJ, van der Molen H, Brinker MG, Hollema H, Ruiters MH, Buys CH, and de Leij LF. (2001). The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy. Cancer Res 61: 4105-11. PubMed

 

McLaughlin PM, Kroesen BJ, Harmsen MC, and de Leij LF. (2001). Cancer immunotherapy: insights from transgenic animal models. Crit Rev Oncol Hematol 40: 53-76. PubMed

 

Meijera C, van Luyn MJ, Nienhuis EF, Blom N, Mulder NH, and de Vries EG. (2001). Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy. Biochem Pharmacol 61: 573-8. PubMed

 

Stevens SJ, Verschuuren EA, Pronk I, van Der BW, Harmsen MC, The TH, Meijer CJ, Van Den Brule AJ, and Middeldorp JM. (2001). Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 97: 1165-71. PubMed

 

The TH, Kas-Deelen AM, de Maar EF, Driessen C, Harmsen MC, and van Son WJ. (2001). Cellular and humoral parameters for vascular damage in blood during cytomegalovirus infections. Transplant Proc 33: 1813. PubMed

 

van der Strate BW, Beljaars L, Molema G, Harmsen MC, and Meijer DK. (2001). Antiviral activities of lactoferrin. Antiviral Res 52: 225-39. PubMed

 

van der Strate BW, Harmsen MC, Schafer P, Swart PJ, The TH, Jahn G, Speer CP, Meijer DK, and Hamprecht K. (2001). Viral load in breast milk correlates with transmission of human cytomegalovirus to preterm neonates, but lactoferrin concentrations do not. Clin Diagn Lab Immunol 8: 818-21. PubMed

 

van Luyn MJ, Plantinga JA, Brouwer LA, Khouw IM, de Leij LF, and van Wachem PB. (2001). Repetitive subcutaneous implantation of different types of (biodegradable) biomaterials alters the foreign body reaction. Biomaterials 22: 1385-91. PubMed

 

van Wachem PB, Brouwer LA, Zeeman R, Dijkstra PJ, Feijen J, Hendriks M, Cahalan PT, and van Luyn MJ. (2001). Tissue reactions to epoxy-crosslinked porcine heart valves post-treated with detergents or a dicarboxylic acid. J Biomed Mater Res 55: 415-23. PubMed

 

van Wachem PB, Plantinga JA, Wissink MJ, Beernink R, Poot AA, Engbers GH, Beugeling T, van Aken WG, Feijen J, and van Luyn MJ. (2001). In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading. J Biomed Mater Res 55: 368-78. PubMed

 

van Wachem PB, Brouwer LA, Kors G, Dijk F, Bel K, Elstrodt J, van WF, Cahalan PT, Hendriks M, and van Luyn MJ. (2001). Animal study on surface-modified defibrillator systems: Indications for enhanced infection resistance. J Biomed Mater Res 58: 384-92. PubMed

 

Verschuuren EA, Stevens S, Hanekamp BB, De BC, Harmsen MC, Middeldorp JM, Koeter G, The TH, and Van Der Bij W. (2001). Patients at risk for post-transplant lymphoproliferative disease can be identified in the first months after lung transplantation by quantitative-competitive-EBV-PCR. J Heart Lung Transplant 20: 199. PubMed

 

Verschuuren EA, Stevens S, Pronk I, Van Der Bij W, Harmsen MC, The TH, Meijer CJ, Van Den Brule AJ, and Middeldorp JM. (2001). Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of post-transplant lymphoproliferative disease in lung transplant patients. J Heart Lung Transplant 20: 199-200. PubMed

 

Verschuuren EA, Popa ER, Van Der Bij W, Harmsen MC, The TH, and Hepkema B. (2001). Donor or recipient origin of post transplant lymphoproliferative disease after lung transplantation. J Heart Lung Transplant 20: 199. PubMed